The Adult Brain Tumor Consortium (ABTC) is a multi-institutional consortium that is supported through a UM1 Cooperative Agreement from the NCI. The consortium performs innovative, multidisciplinary Phase 1 - 2 clinical trials that focus predominantly on adult patients with grade IV gliomas (glioblastoma multiforme). ABTC's objectives are:
The ABTC consists of investigators at premier institutions across the United States. ABTC, and has demonstrated that clinical trials are not only possible in this challenging tumor type, but represent the best hope for making further progress against this devastating disease.